Attached files
| file | filename |
|---|---|
| 10-Q - Eloxx Pharmaceuticals, Inc. | v210553_10q.htm |
| EX-31.2 - Eloxx Pharmaceuticals, Inc. | v210553_ex31-2.htm |
| EX-32.2 - Eloxx Pharmaceuticals, Inc. | v210553_ex32-2.htm |
| EX-31.1 - Eloxx Pharmaceuticals, Inc. | v210553_ex31-1.htm |
| EX-10.1 - Eloxx Pharmaceuticals, Inc. | v210553_ex10-1.htm |
CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350,
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report
on Form 10-Q of Senesco Technologies, Inc. for the period ended December 31,
2010 as filed with the Securities and Exchange Commission on the date hereof,
the undersigned, Leslie J. Browne, Ph.D., President and Chief Executive Officer,
hereby certifies, pursuant to 18 U.S.C. Section 1350, that:
(1) The
Quarterly Report fully complies with the requirements of Section 13(a) or 15(d)
of the Securities Exchange Act of 1934; and
(2) The
information contained in the Quarterly Report fairly presents, in all material
respects, the financial condition and results of operations of Senesco
Technologies, Inc.
|
Dated:
February 10, 2011
|
/s/ Leslie J. Browne *
|
|
Leslie
J. Browne, Ph.D.
|
|
|
President
and Chief Executive Officer
|
|
|
(principal
executive officer)
|
* A
signed original of this written statement required by Section 906 has been
provided to us and will be retained by us and furnished to the Securities and
Exchange Commission or its staff upon request.